CV Sciences, Inc. (OTCMKTS:CVSI) Short Interest Up 506.1% in November

CV Sciences, Inc. (OTCMKTS:CVSI) was the recipient of a large growth in short interest in the month of November. As of November 15th, there was short interest totalling 59,400 shares, a growth of 506.1% from the October 31st total of 9,800 shares. Based on an average trading volume of 484,300 shares, the short-interest ratio is currently 0.1 days.

CV Sciences Stock Performance

OTCMKTS:CVSI remained flat at $0.04 during trading hours on Friday. The company’s stock had a trading volume of 79,254 shares, compared to its average volume of 206,762. The business’s 50-day simple moving average is $0.05 and its two-hundred day simple moving average is $0.05. The firm has a market cap of $7.37 million, a P/E ratio of -3.99 and a beta of 0.59. CV Sciences has a 52 week low of $0.03 and a 52 week high of $0.10.

CV Sciences Company Profile

CV Sciences, Inc develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers.